Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avecho Biotechnology Ltd

OEZ
Current price
0.0005 EUR 0 EUR (0.00%)
Last closed 0.002 AUD
ISIN AU0000047441
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 6 254 689 AUD
Yield for 12 month -50.00 %
1Y
3Y
5Y
10Y
15Y
OEZ
21.11.2021 - 28.11.2021

Avecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. The company was incorporated in 1992 and is based in Clayton, Australia. Address: 2A Westall Road, Clayton, VIC, Australia, 3168

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.55 AUD

P/E ratio

Dividend Yield

Current Year

+467 282 AUD

Last Year

+1 114 311 AUD

Current Quarter

+308 055 AUD

Last Quarter

+26 753 AUD

Current Year

-219 544 AUD

Last Year

+782 618 AUD

Current Quarter

+130 728 AUD

Last Quarter

-430 506 AUD

Key Figures OEZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 277 874 AUD
Operating Margin TTM -694.99 %
PE Ratio
Return On Assets TTM -44.33 %
PEG Ratio
Return On Equity TTM -108.69 %
Wall Street Target Price 2.55 AUD
Revenue TTM 334 807 AUD
Book Value 0.00099 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -30.1 %
Dividend Yield
Gross Profit TTM 782 619 AUD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics OEZ

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History OEZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 19.05.1997
Forward Annual Dividend Yield
Last Split Factor 1.27:1
Payout Ratio
Last Split Date 23.04.1999
Dividend Date

Stock Valuation OEZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 6.6352
Price Sales TTM 18.6815
Enterprise Value EBITDA -6.5575
Price Book MRQ 1.8791

Financials OEZ

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OEZ

For 52 weeks

0.002 AUD 0.0049 AUD
50 Day MA 0.0027 AUD
Shares Short Prior Month
200 Day MA 0.0034 AUD
Short Ratio
Shares Short
Short Percent